Adlai Nortye (ANL) Short Interest Ratio & Short Volume → 41 banks launch ‘crypto dollar’ (From Stansberry Research) (Ad) Free ANL Stock Alerts $13.25 -0.65 (-4.68%) (As of 05/17/2024 08:53 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Adlai Nortye Short Interest DataCurrent Short Volume11,500 sharesPrevious Short Volume5,700 sharesChange Vs. Previous Month+101.75%Dollar Volume Sold Short$158,700.00Short Interest Ratio / Days to Cover1.6Last Record DateApril 30, 2024Outstanding Shares36,900,000 sharesPercentage of Shares Shorted0.03%Today's Trading Volume1,800 sharesAverage Trading Volume6,546 sharesToday's Volume Vs. Average27% Short Selling Adlai Nortye ? Sign up to receive the latest short interest report for Adlai Nortye and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatANL Short Interest Over TimeANL Days to Cover Over TimeANL Percentage of Float Shorted Over Time Ad Stansberry Research41 banks launch ‘crypto dollar’Everyone knows the US financial system is in the middle of a radical change... The White House wants an all-digital dollar. Plus at least 41 major banks (see if your bank is one of them right here).Here's how you capitalize (including #1 crypto to play it). Adlai Nortye Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202411,500 shares $158,700.00 +101.8%N/A1.6 $13.80 4/15/20245,700 shares $62,415.00 -5.0%N/A0.9 $10.95 3/31/20246,000 shares $53,272.80 +42.9%N/A1.2 $8.88 3/15/20244,200 shares $37,800.00 +55.6%N/A3.5 $9.00 2/29/20242,700 shares $19,305.00 -22.9%N/A1.9 $7.15 2/15/20243,500 shares $25,865.00 +6.1%N/A2.5 $7.39 1/31/20243,300 shares $30,128.67 No ChangeN/A1.7 $9.13 ANL Short Interest - Frequently Asked Questions What is Adlai Nortye's current short interest? Short interest is the volume of Adlai Nortye shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 11,500 shares of ANL short. Learn More on Adlai Nortye's current short interest. What is a good short interest ratio for Adlai Nortye? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ANL shares currently have a short interest ratio of 2.0. Learn More on Adlai Nortye's short interest ratio. Is Adlai Nortye's short interest increasing or decreasing? Adlai Nortye saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 11,500 shares, an increase of 101.8% from the previous total of 5,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Adlai Nortye's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Adlai Nortye: Acelyrin, Inc. (13.90%), Entrada Therapeutics, Inc. (9.54%), Oculis Holding AG (0.20%), Fulcrum Therapeutics, Inc. (4.83%), Lexicon Pharmaceuticals, Inc. (9.52%), Annexon, Inc. (6.54%), Theravance Biopharma, Inc. (14.10%), Corbus Pharmaceuticals Holdings, Inc. (6.84%), Larimar Therapeutics, Inc. (6.11%), Travere Therapeutics, Inc. (16.83%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Adlai Nortye stock? Short selling ANL is an investing strategy that aims to generate trading profit from Adlai Nortye as its price is falling. ANL shares are trading down $0.65 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Adlai Nortye? A short squeeze for Adlai Nortye occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ANL, which in turn drives the price of the stock up even further. How often is Adlai Nortye's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ANL, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Travere Therapeutics Short Interest KalVista Pharmaceuticals Short Interest Astria Therapeutics Short Interest Y-mAbs Therapeutics Short Interest Entrada Therapeutics Short Interest Corbus Pharmaceuticals Short Interest Esperion Therapeutics Short Interest Verve Therapeutics Short Interest Applied Therapeutics Short Interest Olema Pharmaceuticals Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ANL) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersShocking: One AI startup's revenue could surge 4,735%Manward PressThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaNext President (Not Trump. Not Biden.)The Freeport SocietyUrgent Nvidia WarningAltimetryElon’s New Device is About to Shock the WorldInvestorPlace"The Biggest Drug Ever" Is ComingBehind the MarketsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders